FDA Drug Approval Summaries: Oxaliplatin
Amna Ibrahim(Beni-Suef University), Richard Pazdur(United States Food and Drug Administration), Donna Griebel(United States Food and Drug Administration), Steven Hirschfeld(United States Food and Drug Administration), Grant A. Williams(United States Food and Drug Administration), Martin H. Cohen(United States Food and Drug Administration)
Cited by 174
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
|The Oncologist|2007|1.4k
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
|Clinical Cancer Research|2019|1.2k